LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Shannon C Peyton"
  2. AU="Shiltsev, V."
  3. AU="Edward S. Debnam"
  4. AU="Freeston, Sarah L"
  5. AU="Bertolucci, S."
  6. AU="de Barros, Rosires M B"
  7. AU="Carr, Crystal C"
  8. AU="Davies, Mark Lloyd"
  9. AU=St Gelais Corine
  10. AU=Engstrom Malitta
  11. AU="Hongo, Akane"
  12. AU="Krykorková, I"
  13. AU=Yan Bing
  14. AU="Nakos, Konstantinos"
  15. AU="Schreiner, Ryan"
  16. AU=Pltz T
  17. AU="Akhmanova, Anna" AU="Akhmanova, Anna"
  18. AU="Goretsky, Anton"
  19. AU="Cordoza, Makayla L"
  20. AU=Midoux Patrick AU=Midoux Patrick
  21. AU="Mundt, H M"
  22. AU=Tsivitse Susan

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease

    Elizabeth A Scoville / Hilary A Tindle / Quinn S Wells / Shannon C Peyton / Shelly Gurwara / Stephanie O Pointer / Sara N Horst / David A Schwartz / Dawn W Adams / Matthew S Freiberg / Vanessa Gatskie / Stephen King / Lesa R Abney / Dawn B Beaulieu

    PLoS ONE, Vol 15, Iss 3, p e

    A pilot study.

    2020  Band 0230656

    Abstract: Introduction Smoking is a strong risk factor for disease severity in Crohn's disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine ... ...

    Abstract Introduction Smoking is a strong risk factor for disease severity in Crohn's disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine replacement therapy (NRT) for "normal", but not "slow" metabolizers. Varenicline side effects are heightened in slow metabolizers. Methods using NMR to optimize cessation pharmacotherapy have not been evaluated in CD. Aims We aim to determine the prevalence of smoking in a CD population and then assess these smokers' attitudes toward a personalized metabolism-informed care (MIC) approach to cessation. Methods In this observational study, we surveyed 1098 patients visiting an inflammatory bowel disease center about their smoking history. We then evaluated a subgroup of individuals with CD (n = 32) who participated in a randomized controlled trial of smoking cessation using MIC versus usual care. For MIC, medication selection was informed by the NMR (normal ≥0.31 vs. slow <0.31). The primary outcomes were intervention satisfaction and match rates between NMR and medication choice. Results The baseline prevalence of smoking in our CD population was 13%. Intervention participants reported high rates of satisfaction (85%) and chose a medication that matched their NMR result more often in the MIC group (100% vs. 64%, p = 0.01). Six of 16 (37.5%) patients prescribed varenicline discontinued due to side effects. Conclusion MIC produced high rates of satisfaction and matching between NMR and medication in CD patients, supporting patient acceptance and feasibility of precision smoking cessation in this population. To reduce smoking in CD, therapies such as MIC are needed to maximize efficacy and minimize side effects.
    Schlagwörter Medicine ; R ; Science ; Q
    Thema/Rubrik (Code) 610
    Sprache Englisch
    Erscheinungsdatum 2020-01-01T00:00:00Z
    Verlag Public Library of Science (PLoS)
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn’s Disease

    Elizabeth A. Scoville / Margaret M. Allaman / Dawn W. Adams / Amy K. Motley / Shannon C. Peyton / Sarah L. Ferguson / Sara N. Horst / Christopher S. Williams / Dawn B. Beaulieu / David A. Schwartz / Keith T. Wilson / Lori A. Coburn

    Scientific Reports, Vol 9, Iss 1, Pp 1-

    2019  Band 11

    Abstract: Abstract Crohn’s disease (CD) has been associated with an increased consumption of n-6 polyunsaturated fatty acid (PUFA), while greater intake of n-3 PUFA has been associated with a reduced risk. We sought to investigate serum fatty acid composition in ... ...

    Abstract Abstract Crohn’s disease (CD) has been associated with an increased consumption of n-6 polyunsaturated fatty acid (PUFA), while greater intake of n-3 PUFA has been associated with a reduced risk. We sought to investigate serum fatty acid composition in CD, and associations of fatty acids with disease activity, cytokines, and adipokines. Serum was prospectively collected from 116 CD subjects and 27 non-IBD controls. Clinical disease activity was assessed by the Harvey Bradshaw Index (HBI). Serum fatty acids were measured by gas chromatography. Serum cytokines and adipokines were measured by Luminex assay. Dietary histories were obtained from a subset of patients. Nine serum cytokines and adipokines were increased in CD versus controls. CD subjects had increased percentage serum monounsaturated fatty acids (MUFA), dihomo-gamma linolenic acid (DGLA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and oleic acid, but decreased arachidonic acid (AA) versus controls. The % total n-3 fatty acids and % EPA directly correlated with pro-inflammatory cytokine levels and HBI, whereas the % total n-6 fatty acids were inversely correlated with pro-inflammatory cytokine levels and HBI. CD subjects had increased caloric intake versus controls, but no alterations in total fat or PUFA intake. We found differences in serum fatty acids, most notably PUFA, in CD that correlated both with clinical disease activity and inflammatory cytokines. Our findings indicate that altered fatty acid metabolism or utilization is present in CD and is related to disease activity.
    Schlagwörter Medicine ; R ; Science ; Q
    Sprache Englisch
    Erscheinungsdatum 2019-02-01T00:00:00Z
    Verlag Nature Publishing Group
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang